Skip to main content
Lee Nadler, MD, Oncology, Boston, MA

LeeMarshallNadlerMD

Oncology • Boston, MA

Virginia and D.K. Ludwig Professor of Medicine, Harvard Medical School

Join to view full profile

Dr. Nadler is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Nadler's full profile

Already have an account?

  • Office

    44 Binney St
    Smith Building, Suite 339
    Boston, MA 02115
    Phone+1 617-632-3331

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1977 - 1980
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1973 - 1975
  • Harvard Medical School
    Harvard Medical SchoolClass of 1973

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1977 - 2025
  • ME State Medical License
    ME State Medical License Active through 1984
  • MD State Medical License
    MD State Medical License 1975 - 1979
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1989
  • Super Doctor SuperDoctors.com

Publications & Presentations

PubMed

Press Mentions

  • Growing Value and Opportunity for Integrative Oncology in Hospital Settings
    Growing Value and Opportunity for Integrative Oncology in Hospital SettingsSeptember 10th, 2019
  • Seasoned Scientific Experts and Strategic Pharmaceutical Industry Veterans Join Cerenis’ Scientific Advisory Board in Oncology
    Seasoned Scientific Experts and Strategic Pharmaceutical Industry Veterans Join Cerenis’ Scientific Advisory Board in OncologyMay 7th, 2018
  • Des Decideurs, Veterans De L’industrie Pharmaceutique Et Des Experts De Renommee Mondiale Se Joignent Au Conseil Scientifique Oncologie De Cerenis
    Des Decideurs, Veterans De L’industrie Pharmaceutique Et Des Experts De Renommee Mondiale Se Joignent Au Conseil Scientifique Oncologie De CerenisMay 2nd, 2018
  • Join now to see all

Grant Support

  • Harvard Clinical And Translational Science Center (UL1)National Center For Research Resources2008–2011
  • Harvard Clinical And Translational Science Center (TL1)National Center For Research Resources2008–2011
  • Harvard Clinical And Translational Science Center (KL2)National Center For Research Resources2008–2011
  • CTSA Infrastructure For Pediatric ResearchNational Center For Research Resources2008–2011
  • CTSA Infrastructure For Clinical TrialsNational Center For Research Resources2008–2011
  • CTSA Infrastructure For AIDS ResearchNational Center For Research Resources2008–2011
  • Networking Research Resources Across AmericaNational Center For Research Resources2009–2010
  • Specific Control Of Donor Anti-Host AlloreactiviyNational Cancer Institute2008
  • Administrative CoreNational Cancer Institute2008
  • Rebuilding Immunity For SurvivalNational Cancer Institute2006–2008
  • Rebuilding Immunity For SurvivalNational Cancer Institute2003–2005
  • T Cell Immunity In Germinal Center B Cell LymphomaNational Cancer Institute2001–2002
  • Translational Therapeutic Strategies In Acute Lymphocytic LeukemiaNational Cancer Institute2000–2002
  • Antigen Specific Immunity In Multiple MyelomaNational Cancer Institute1998–2002
  • Molecular Pathways Regulating T Cell Anergy To AlloantigenNational Institute Of Allergy And Infectious Diseases1997–2001
  • Induction Of Host-Specific Tolerance In Allogenic BMTNational Institute Of Allergy And Infectious Diseases1997–2001
  • Induction Of T Cell Mediated Tumor Specific Immunity Against Leukemia &LymphomaNational Cancer Institute1996–2001
  • Selective Depletion Of T Cells From Donor Bone MarrowNational Heart, Lung, And Blood Institute1996–1999
  • Selective Depletion Of T Cells From Donor Bone MarrowNational Heart, Lung, And Blood Institute1996–1997
  • Novel Cd28/Ctla4 Counter-ReceptorsNational Cancer Institute1995–1997
  • Induction Of Host-Specific Tolerance In Allogeneic BMTNational Institute Of Allergy And Infectious Diseases1993–1996
  • Function Of The B7 Antigen On Normal/Neoplastic B CellsNational Cancer Institute1991–1994
  • Characterization Of Human B-Cell Activation AntigensNational Cancer Institute1985–1990

Dr. Lee Nadler, Dr. Lee Nadler, MD, Dr. L Nadler, Dr. Lee Marshall Nadler